BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy associated with poor survival rates. Fast detection of PDAC appears to be the most relevant strategy to improve the long-term survival of patients. AIMS: Our objective was to identify new markers in peripheral blood that differentiates between PDAC patients and healthy controls. METHODS: Peripheral blood samples from PDAC patients (n = 18) and controls (n = 18) were analyzed by whole genome cDNA microarray hybridization. The most relevant genes were validated by quantitative real-time PCR (RT-qPCR) in the same set of samples. Finally, our gene prediction set was tested in a blinded set of new peripheral blood samples (n = 30). RESULTS: Microarray studies identified 87 genes differentially expressed in peripheral blood samples from PDAC patients. Four of these genes were selected for analysis by RT-qPCR, which confirmed the previously observed changes. In our blinded validation study, the combination of CLEC4D and IRAK3 predicted the diagnosis of PDAC with 93 % accuracy, with a sensitivity of 86 % and specificity of 100 %. CONCLUSIONS: Peripheral blood gene expression profiling is an useful tool for the diagnosis of PDAC. We present a validated four-gene predictor set (ANKRD22, CLEC4D, VNN1, and IRAK3) that may be useful in PDAC diagnosis.
BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy associated with poor survival rates. Fast detection of PDAC appears to be the most relevant strategy to improve the long-term survival of patients. AIMS: Our objective was to identify new markers in peripheral blood that differentiates between PDACpatients and healthy controls. METHODS: Peripheral blood samples from PDACpatients (n = 18) and controls (n = 18) were analyzed by whole genome cDNA microarray hybridization. The most relevant genes were validated by quantitative real-time PCR (RT-qPCR) in the same set of samples. Finally, our gene prediction set was tested in a blinded set of new peripheral blood samples (n = 30). RESULTS: Microarray studies identified 87 genes differentially expressed in peripheral blood samples from PDACpatients. Four of these genes were selected for analysis by RT-qPCR, which confirmed the previously observed changes. In our blinded validation study, the combination of CLEC4D and IRAK3 predicted the diagnosis of PDAC with 93 % accuracy, with a sensitivity of 86 % and specificity of 100 %. CONCLUSIONS: Peripheral blood gene expression profiling is an useful tool for the diagnosis of PDAC. We present a validated four-gene predictor set (ANKRD22, CLEC4D, VNN1, and IRAK3) that may be useful in PDAC diagnosis.
Authors: A Rogers; M J Smith; P Doolan; C Clarke; M Clynes; J F Murphy; A McDermott; N Swan; P Crotty; P F Ridgway; K C Conlon Journal: Pancreatology Date: 2011-12-31 Impact factor: 3.996
Authors: Patrick A M Jansen; Marijke Kamsteeg; Diana Rodijk-Olthuis; Ivonne M J J van Vlijmen-Willems; Gys J de Jongh; Mieke Bergers; Geuranne S Tjabringa; Patrick L J M Zeeuwen; Joost Schalkwijk Journal: J Invest Dermatol Date: 2009-03-26 Impact factor: 8.551
Authors: Zarir E Karanjawala; Peter B Illei; Raheela Ashfaq; Jeffrey R Infante; Kathleen Murphy; Akhilesh Pandey; Richard Schulick; Jordan Winter; Rajni Sharma; Anirban Maitra; Michael Goggins; Ralph H Hruban Journal: Am J Surg Pathol Date: 2008-02 Impact factor: 6.394
Authors: Natalie C Twine; Jennifer A Stover; Bonnie Marshall; Gary Dukart; Manuel Hidalgo; Walter Stadler; Theodore Logan; Janice Dutcher; Gary Hudes; Andrew J Dorner; Donna K Slonim; William L Trepicchio; Michael E Burczynski Journal: Cancer Res Date: 2003-09-15 Impact factor: 12.701
Authors: Michael J Baine; Subhankar Chakraborty; Lynette M Smith; Kavita Mallya; Aaron R Sasson; Randall E Brand; Surinder K Batra Journal: PLoS One Date: 2011-02-10 Impact factor: 3.240
Authors: James T Rosenbaum; Dongseok Choi; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Cailin H Sibley; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant Parekh; Gerald J Harris; Michael Kazim; Payal Patel; Valerie White; Peter Dolman; Bobby S Korn; Don Kikkawa; Deepak P Edward; Hind Alkatan; Hailah Al-Hussain; R Patrick Yeatts; Dinesh Selva; Patrick Stauffer; Stephen R Planck Journal: JAMA Ophthalmol Date: 2015-07 Impact factor: 7.389
Authors: Liwei Cao; Chen Huang; Daniel Cui Zhou; Yingwei Hu; T Mamie Lih; Sara R Savage; Karsten Krug; David J Clark; Michael Schnaubelt; Lijun Chen; Felipe da Veiga Leprevost; Rodrigo Vargas Eguez; Weiming Yang; Jianbo Pan; Bo Wen; Yongchao Dou; Wen Jiang; Yuxing Liao; Zhiao Shi; Nadezhda V Terekhanova; Song Cao; Rita Jui-Hsien Lu; Yize Li; Ruiyang Liu; Houxiang Zhu; Peter Ronning; Yige Wu; Matthew A Wyczalkowski; Hariharan Easwaran; Ludmila Danilova; Arvind Singh Mer; Seungyeul Yoo; Joshua M Wang; Wenke Liu; Benjamin Haibe-Kains; Mathangi Thiagarajan; Scott D Jewell; Galen Hostetter; Chelsea J Newton; Qing Kay Li; Michael H Roehrl; David Fenyö; Pei Wang; Alexey I Nesvizhskii; D R Mani; Gilbert S Omenn; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Oliver F Bathe; Daniel W Chan; Ralph H Hruban; Li Ding; Bing Zhang; Hui Zhang Journal: Cell Date: 2021-09-16 Impact factor: 66.850
Authors: Galyna Bondar; Ryan Togashi; Martin Cadeiras; Joanna Schaenman; Richard K Cheng; Lindsay Masukawa; Josephine Hai; Tra-Mi Bao; Desai Chu; Eleanor Chang; Maral Bakir; Sophie Kupiec-Weglinski; Victoria Groysberg; Tristan Grogan; Joseph Meltzer; Murray Kwon; Maura Rossetti; David Elashoff; Elaine Reed; Pei Pei Ping; Mario C Deng Journal: PLoS One Date: 2017-12-13 Impact factor: 3.240
Authors: Heloisa H Milioli; Inna Tishchenko; Carlos Riveros; Regina Berretta; Pablo Moscato Journal: BMC Med Genomics Date: 2017-03-28 Impact factor: 3.063
Authors: Antonio Irigoyen; Cristina Jimenez-Luna; Manuel Benavides; Octavio Caba; Javier Gallego; Francisco Manuel Ortuño; Carmen Guillen-Ponce; Ignacio Rojas; Enrique Aranda; Carolina Torres; Jose Prados Journal: PLoS One Date: 2018-04-04 Impact factor: 3.240